Stock A004720 PHARMGEN SCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company PharmGen Science, Inc.

Equities

A004720

KR7004720009

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 08/05/2024 BST 		5-day change 1st Jan Change
5,370 KRW 0.00% Intraday chart for PharmGen Science, Inc. +0.94% -13.39%
2023 PharmGen Science, Inc.(KOSE:A004720) dropped from S&P Global BMI Index CI
2023 PharmGen Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Business Summary

PharmGen Science Inc, formerly Wooridul Pharmaceutical Ltd, is a Korea-based company principally engaged in the manufacturing and distribution of pharmaceuticals. The Company’s products include antiepileptic agents, anti-inflammatory agents, antiphlogistic agents, central nervous system agents, urinary agents, antihistamine agents, antivirus agents, agents for bones, agents for livers, calcium agents, antibiotics, diabetes agents, respiratory agents, as well as over-the-counter (OTC) drugs, obesity drugs, health food and others. In addition, the Company is also engaged in the manufacturing, wholesale and retail distribution of functional cosmetics. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 250

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
150,931 100.0 % 166,779 100.0 % +10.50%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
99.5 %
150,065 99.4 % 165,885 99.5 % +10.54%
Overseas
0.5 %
866 0.6 % 894 0.5 % +3.28%

Managers

Managers TitleAgeSince
Hee-Deok Park CEO
 Chief Executive Officer 56 26/03/19
Hye-Yeon Kim CEO
 Chief Executive Officer 67 -
Nam-Hyun Ryu BRD
 Director/Board Member 58 -
Seung-Yeol Lee BRD
 Director/Board Member 44 -
Seo-In Kim AUD
 Comptroller/Controller/Auditor 42 25/03/20
Hae-Doo Lee PRN
 Corporate Officer/Principal 61 -

Members of the board

Members of the board TitleAgeSince
Seung-Yeol Lee BRD
 Director/Board Member 44 -
Hye-Yeon Kim CEO
 Chief Executive Officer 67 -
Nam-Hyun Ryu BRD
 Director/Board Member 58 -
Hee-Deok Park CEO
 Chief Executive Officer 56 26/03/19
Dong-Hwa Yoon BRD
 Director/Board Member 63 -
In-Ki Lee BRD
 Director/Board Member 61 25/03/20
Kwang-Hae Lee BRD
 Director/Board Member 52 25/03/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,178,525 15,763,523 ( 86.72 %) 41,910 ( 0.2305 %) 86.72 %

Shareholders

NameEquities%Valuation
HD Investment Association
4.786 %
870,000 4.786 % 4 M ₩
Hyun-sook Kim
3.826 %
695,564 3.826 % 3 M ₩
Eui-Sang Han
2.307 %
419,463 2.307 % 2 M ₩
Dae-hee Han
1.143 %
207,785 1.143 % 870 499 ₩
Geun Hee Han
0.4615 %
83,892 0.4615 % 351 459 ₩
PHARMGEN SCIENCE, INC.
0.2305 %
41,910 0.2305 % 175 579 ₩
Hye-Yeon Kim
0.1649 %
29,979 0.1649 % 125 595 ₩
Soo-myung Han
0.0609 %
11,074 0.0609 % 46 394 ₩
Dimensional Fund Advisors Ltd.
0.0402 %
7,310 0.0402 % 30 625 ₩
Mirae Asset Global Investments Co., Ltd.
0.004896 %
890 0.004896 % 3 729 ₩

Holdings

NameEquities%Valuation
ACCESS BIO, INC.
25.22%
 9,171,729 25.22% 50,823,485 $
PHARMGEN SCIENCE, INC.
0.23%
 41,910 0.23% 175,579 $

Company contact information

PharmGen Science, Inc.

50 Pharmaceutical Ind. Complex 2-gil Hyangnam-myeon

18622, Hwaseong

+

http://www.pharmgenscience.com
address PharmGen Science, Inc.(A004720)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
PHARMGEN SCIENCE, INC. Stock PharmGen Science, Inc.
-13.39% 71.36M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+18.67% 43.74B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+21.99% 22.26B
SANDOZ GROUP AG Stock Sandoz Group AG
+16.41% 14.9B
CIPLA LIMITED Stock Cipla Limited
+9.03% 13.39B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+40.48% 12.12B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.64% 6.92B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.41% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A004720 Stock
  4. Company PharmGen Science, Inc.